<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02491671</url>
  </required_header>
  <id_info>
    <org_study_id>HEMOPATCH/FAP/2014</org_study_id>
    <nct_id>NCT02491671</nct_id>
  </id_info>
  <brief_title>Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung Resection</brief_title>
  <official_title>Prospective, Multicenter, Open-Label, Randomized, Phase III Clinical Trial of Prevention of Prolonged Air Leak After Lung Resection in High-risk Patients, Applying HEMOPATCH®</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IBSAL-Instituto de Investigación Biomédica de Salamanca, Fundación IECSCYL-IBSAL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effectiveness of tissue sealants to prevent Prolonged Air Leak (PAL) after lung resection
      procedures remains unproved. The investigators hypothesize that one of the main reasons for
      that is the heterogeneity of previously studied populations. Since currently the risk of
      postoperative PAL can be scored with a reasonable accuracy, the aim of this research is to
      investigate the effect of routine application of a novel tissue sealant in patients selected
      on the basis of a high risk of PAL estimated before surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of Prolonged Air Leak (PAL)</measure>
    <time_frame>From day of surgery to the fifth postoperative day</time_frame>
    <description>Measured as binary variable (YES/NO) and recorded, from day of surgery to the fifth postoperative day, in the study questionnaire. The occurrence of the outcome will be recorded if air leak exists 5 days or more after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of air leaks</measure>
    <time_frame>Check everyday from day of surgery up to 30 days post-operative at maximum</time_frame>
    <description>Measured as continuos variable (days) and recorded, from day of surgery to the day of withdraw the chest tube. (standardized criteria for pulling out chest drainage/s will be agreed among investigators)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chest tube reinsertion rate</measure>
    <time_frame>From day of surgery up to 30 days thereafter</time_frame>
    <description>Rate of patients needing postoperative reinsertion of chest drainages due to symptomatic pneumothorax. Following daily during hospital stay and pone follow-up until 30th day post-operative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>30 days post-operative</time_frame>
    <description>Rate of readmissions due to relapsing pneumothorax (follow-up 30 days)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">276</enrollment>
  <condition>Prolonged Air Leak</condition>
  <condition>Lung Resection</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental group: At the end of lung resection, lung sutures and 1.5 cm of lung parenchyma on each side will be covered by Hemopatch. No additional measures for preventing air leak will be indicated. In the case of massive air leak in spite of the use of Hemopatch, each surgeon will decide on the indication of additional sutures of tissue plasties. These cases will be accounted for failures on an intention to treat basis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control group: The standard preventive measures will be followed in each center, including reinforcement of sutures, pleural tents, suturing pericardial or subcutaneous fat</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hemopatch</intervention_name>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>standard preventive measures</intervention_name>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled anatomical lung resection indicated for any non-infectious disease
             (excluding Pneumonectomy)

          -  Patients classified in class D according estimated risk of PAL

          -  Age between 18 and 80 years

        Exclusion Criteria:

          -  Those patients that according to Investigator assessment are not going to tolerate the
             procedure

          -  Clinical and anesthetic criteria that contraindicate surgery

          -  Severe uncontrolled illness

          -  Pregnancy

          -  Patients that are under Investigational New Drug treatment or have participated in
             study with a investigational drug (authorized or not) in 30 days before randomization.

          -  Lack of Informed Consent or patient refusal

          -  Postsurgery mechanical ventilation or repeated surgery in follow-up month.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gonzalo Varela, MD PhD FETCS</last_name>
    <role>Study Director</role>
    <affiliation>IBSAL-Instituto de Investigación Biomédica de Salamanca</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gonzalo Varela, MD PhD FETCS</last_name>
    <phone>+34 923 291100</phone>
    <phone_ext>55383</phone_ext>
    <email>gvs@usal.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marcelo F. Jimenez, MD PhD FETCS</last_name>
    <phone>+34 923 291100</phone>
    <phone_ext>55383</phone_ext>
    <email>mfjl@usal.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla de Santander</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Sánchez, Ph.D.</last_name>
      <phone>+34 942038436</phone>
      <email>lasanchez@humv.es</email>
    </contact>
    <investigator>
      <last_name>Laura Sánchez, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Sánchez, Ph.D.</last_name>
      <phone>932275400</phone>
      <email>DSANCHE1@clinic.cat</email>
    </contact>
    <investigator>
      <last_name>David Sánchez, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal de Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolás Moreno, Ph.D.</last_name>
      <phone>+34 913368048</phone>
      <email>nico1477@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Nicolás Moreno, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florentino Hernando, Ph.D.</last_name>
      <phone>+34913303168</phone>
      <email>fhtrancho@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Florentino Hernando, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Salamanca (CAUSA)</name>
      <address>
        <city>Salamanca</city>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcelo F. Jiménez, MD PhD FECTS</last_name>
      <phone>+34 923291100</phone>
      <phone_ext>55383</phone_ext>
      <email>mfjl@usal.es</email>
    </contact>
    <investigator>
      <last_name>Marcelo F. Jiménez, MD PhD FECTS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana-Isabel Blanco, M.D.</last_name>
      <email>aiblancoo@telefonica.net</email>
    </contact>
    <investigator>
      <last_name>Ana-Isabel Blanco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2015</study_first_submitted>
  <study_first_submitted_qc>July 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2015</study_first_posted>
  <last_update_submitted>October 9, 2017</last_update_submitted>
  <last_update_submitted_qc>October 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prevention PAL Prolonged Air Leak (PAL)</keyword>
  <keyword>Lung Resection</keyword>
  <keyword>Thoracic Surgery</keyword>
  <keyword>Post-operative Thoracic Air Leak</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

